INGN - NASDAQ
Inogen, Inc.
$6.09
+6.1%Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
At a Glance
Live Snapshotingn
Total Non-Current Liabilities
Last Annual Value
42.86M
3-Year CAGR
%
5-Year CAGR
-5%
10-Year CAGR
23%
Inogen, Inc. Competitors Analysis of Total Non-Current Liabilities
| Company | Total Non-Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Inogen, Inc. NASDAQ:INGN | 42.86M | -4.3% | -5.8% | 16.7% | |
 Perspective Therapeutics, Inc. AMEX:CATX | 31.26M | 64.3% | 98.4% | 49.5% | |
 CVRx, Inc. NASDAQ:CVRX | 52.15M | 18.4% | 138.1% | N/A | |
 OraSure Technologies, Inc. NASDAQ:OSUR | 22.55M | 21.3% | 12.7% | 16.9% | |
 SELLAS Life Sciences Group, Inc. NASDAQ:SLS | 457.00K | -0.2% | -16.1% | -23.6% | |
 Electromed, Inc. AMEX:ELMD | 125.00K | 13.3% | 18.3% | -19.9% | |
 Shoulder Innovations, Inc. NYSE:SI | 14.96M | -45.0% | N/A | N/A | |
 Quanterix Corporation NASDAQ:QTRX | 80.21M | 26.5% | 22.9% | 20.3% | |
 Health Catalyst, Inc. NASDAQ:HCAT | 167.29M | -12.0% | -5.1% | N/A | |
 Outset Medical, Inc. NASDAQ:OM | 99.91M | -9.7% | 21.5% | N/A | |
 SANUWAVE Health, Inc. NASDAQ:SNWV | 17.88M | 177.2% | 68.6% | N/A |
Inogen, Inc. Fair Value Envelope
Related Guides
Continue your INGN research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.